Document is current
Any future updates will be listed below
-
Authors
Caniff, Kaylee E.
Judd, Chloe
Lucas, Kristen
Goro, Sandra
Orzol, Caroline
Eshaya, Mirna
Al Musawa, Mohammed
Veve, Michael P.
Rybak, Michael J. https://orcid.org/0000-0002-1094-043X
- License Information
-
More Information
Article History
Received: 30 August 2024
Accepted: 10 October 2024
First Online: 2 November 2024
Declarations
:
: Kaylee E. Caniff, Chloe Judd, Kristen Lucas, Sandra Goro, Caroline Orzol, Mirna Eshaya. Mohammed Al Musawa. and Michael P. Veve have no conflicts of interest to report. Michael J. Rybak is a consultant and has received grant funding from Abbvie and has received grant funding from Merck & Co. Michael J. Rybak is an Editor-in-Chief of <i>Infectious Diseases and Therapy</i> and was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. Approval for this study was obtained from the Henry Ford Healthcare Institutional Review Board (#16481-01) and the Wayne State University Institutional Review Board (#22-11-5172) with Detroit Medical Center research authorization. This study received a waiver for the requirement of patient consent given the retrospective design.
